GenomOncology provides a comprehensive suite of end-to-end clinical informatics solutions for cancer, built upon its core Precision Oncology Platform (POP). POP is an augmented intelligence stack that houses extensive rules, annotations, and ontologies, enabling users to move, convert, and interpret complex genomic and clinical data sets.
Key Product Solutions:
- GO Pathology Workbench (PWB): An end-to-end tertiary analysis solution for NGS and non-NGS data. It integrates directly with lab systems (EHR, LIMS, sequencers), automates somatic and germline variant interpretation (following AMP/ASCO/CAP and ACMG guidelines), matches patients to personalized therapy and clinical trial options, and produces fully customized reports (PDF, XML, DOCX, TXT, HL7).
- Precision Decision: A flexible solution providing real-time decision support and informed guidance for cancer diagnosis, treatment, and management by leveraging medical data, clinical guidelines, and computational algorithms.
- GenomAnalytics: A visualization and statistical analysis tool that utilizes POP to analyze molecular, clinical, demographic, and treatment data in one comprehensive view.
- igniteIQ: A data enablement solution that extracts clinically-relevant, discrete data from unstructured and semi-structured documents for registries, analytics, and research.
- GO Precision Oncology API Suite: A comprehensive API that allows clinicians, researchers, and collaborative teams to extend the platform's knowledge by integrating directly with their in-house systems and existing workflows.
Target Users and Use Cases:
The software is purpose-built for molecular pathology labs, oncologists, researchers, and healthcare institutions. Primary use cases include automating genomic reporting into the EHR, standardizing genomic variant interpretation and classification, facilitating molecular tumor board review, and improving clinical trial matching and patient treatment decisions.